“Progeria”的搜索结果，显示 1-10 项，共有 608 项

1. 早老症- 症状与病因- 妙佑医疗国际

   Progeria: About the disease. Genetic and Rare Diseases Information Center ... Kliegman RM, et al. Hutchinson-Gilford progeria syndrome (progeria). In ...

2. 早老症- 诊断与治疗- 妙佑医疗国际

   Progeria Research Foundation. https://www.progeriaresearch.org/about-us/. Accessed Nov. 28, 2022. Pichurin PN (expert opinion). Mayo Clinic. Feb. 13, 2023.

3. 早老症- 医生与科室- 妙佑医疗国际

   这种遗传性疾病极为罕见且具有进行性。该病的患儿在两岁前开始迅速衰老。

4. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood, and to establish the feasibility and safety of Dasatinib ...

5. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood, and to establish the feasibility and safety of Dasatinib ...

6. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on ...

7. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this registry is to collect clinical, diagnostic, and therapeutic data specific for primary spinal column tumor patients, and evaluate it to ...

8. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this registry is to collect clinical, diagnostic, and therapeutic data specific for primary spinal column tumor patients, and evaluate it to ...

9. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this registry is to collect clinical, diagnostic, and therapeutic data specific for primary spinal column tumor patients, and evaluate it to ...

10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood, and to establish the feasibility and safety of Dasatinib ...